Enrolling by invitationNot applicableNCT06606340
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice
Studying Duchenne muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sarepta Therapeutics, Inc.
- Intervention
- Eteplirsen(drug)
- Enrollment
- 300 enrolled
- Eligibility
- MALE
- Timeline
- 2019 – 2033
Study locations (20)
- Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- University of Florida, Gainesville, Florida, United States
- University Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- Washington University, St Louis, Missouri, United States
- Columbia University Medical Center - PIN, New York, New York, United States
- Duke Lenox Baker Children's Hospital, Durham, North Carolina, United States
- Atrium Health Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06606340 on ClinicalTrials.govOther trials for Duchenne muscular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07332013Urinary Titin Biomarker in DMDChildren's Hospital of Philadelphia
- RECRUITINGNCT07092540The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyUniversity of Rochester
- ENROLLING BY INVITATIONNANCT06887491The Effect of Dual-tasking Program on Cognitive and Physical Functions and Independence in Activities of Daily Living in Children With Duchenne Muscular Dystrophy: A Single-blind Randomized Controlled TrialLokman Hekim University
- ACTIVE NOT RECRUITINGPHASE1NCT07347548A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male ParticipantsGrünenthal GmbH
- ENROLLING BY INVITATIONPHASE2NCT07209332Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular DystrophyWave Life Sciences Ltd.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07282652A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular DystrophyPeking Union Medical College Hospital
- RECRUITINGPHASE2NCT07287189Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsSatellos Bioscience, Inc.
- ENROLLING BY INVITATIONNCT07435116Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb MusclesSanko University